GPR30 is able to bind 17β-estradiol and allows fast nongenomic responses of estrogens such as the stimulation of MAPK pathways, adenylyl cyclase, or c-fos expression in the breast cancer cell line SKBR3 which does not express the classical ERs [127–129]. Here, FOS is linked to breast cancer.